Colfax Corporation [NYSE:CFX]: Analyst Rating and Earnings

Pro stock market traders often keep their attention pointed at what top market analysts have to say regarding a potential equity investment. For Colfax Corporation [CFX] currently, the latest-available mean analyst rating is for the fiscal quarter that will end in December. On average, stock market experts give CFX an Outperform rating. Its stock price has been found in the range of 18.95 to 37.05. This is compared to its latest closing price of $25.93.

Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for Colfax Corporation [CFX] is sitting at 2.35. This is compared to 1 month ago, when its average rating was 2.35.

For the quarter ending in Mar-19 Colfax Corporation [CFX] generated $1.01 billion in sales. That’s 3.22% lower than the average estimate of $1.04 billion as provided by Wall Street analysts. The three indicators above suggest that on the whole, this stock is not presenting an attractive investment option, as there are too many red flags that don’t point to a high-value ROI.

Keep your eyes peeled for this company’s upcoming financial results publication, which is slated for Mon 5 Aug (In 82 Days).

Fundamental Analysis of Colfax Corporation [CFX]

Now let’s turn to look at profitability: with a current Operating Margin for Colfax Corporation [CFX] sitting at +8.25 and its Gross Margin at +28.49, this company’s Net Margin is now 1.70%. These metrics indicate that this company is not generating as much profit, after accounting for expenses, compared to its market peers.

This company’s Return on Total Capital is 6.39, and its Return on Invested Capital has reached 5.00%. Its Return on Equity is 4.98, and its Return on Assets is 2.53. These metrics suggest that this Colfax Corporation does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.

Turning to investigate this organization’s capital structure, Colfax Corporation [CFX] has generated a Total Debt to Total Equity ratio of 36.66. Similarly, its Total Debt to Total Capital is 26.83, while its Total Debt to Total Assets stands at 18.15. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is 36.47, and its Long-Term Debt to Total Capital is 26.68. This company is not leveraging its assets to take on debt, which stunts its growth and limits the ROI for investors.

What about valuation? This company’s Enterprise Value to EBITDA is 9.30 and its Total Debt to EBITDA Value is 2.70. The Enterprise Value to Sales for this firm is now 1.09, and its Total Debt to Enterprise Value stands at 0.33. Colfax Corporation [CFX] has a Price to Book Ratio of 0.75, a Price to Cash Flow Ratio of 11.15 and P/E Ratio of 42.52. These metrics show that this company has a mixed appeal, and ROI could be a gain or a loss.

Shifting the focus to workforce efficiency, Colfax Corporation [CFX] earns $236,569 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 3.74 and its Total Asset Turnover is 0.55. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 1.22 and its Current Ratio is 1.63. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

Colfax Corporation [CFX] has 116.38M shares outstanding, amounting to a total market cap of $3.02B. Its stock price has been found in the range of 18.95 to 37.05. At its current price, it has moved by -29.93% from its 52-week high, and it has moved 36.99% from its 52-week low.

This stock’s Beta value is currently 1.60, which indicates that it is more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 26.46. This stock, according to these metrics, is currently Oversold.

Conclusion: Is Colfax Corporation [CFX] a Reliable Buy?

Colfax Corporation [CFX] stock is presenting a less attractive investment opportunity when compared to similarly-sized corporations in the same industry. The price performance of these shares has not shown much promise, and the financial results that this company has recently delivered present a highly risky investment.